Portfolio Update

BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC

All information is at 31 October 2014 and unaudited.

Performance at month end with net income reinvested

                               One  Three   One   Since  Three   Five
                             month months  year 1 April  years  years
Sterling:                                          2012
Share price                  -2.0%   0.5%  5.2%   38.6%  40.0%  62.3%
Net asset value               0.3%   0.6%  6.3%   29.4%  38.4%  62.6%
FTSE All-Share Total Return  -0.7%  -1.4%  1.0%   27.8%  36.2%  61.0%

Sources: BlackRock and Datastream

BlackRock took over the investment management of the Company with effect from 1
April 2012.

At month end
Sterling:
Net asset value - capital only:         167.14p
Net asset value - cum income*:          170.71p
Share price:                            167.25p
Total assets (including income):         £47.2m
Discount to cum-income NAV:                2.0%
Net cash:                                  1.6%
Net yield**:                               3.4%
Ordinary shares in issue***:         26,479,268
Gearing range (as a % of net assets)      0-20%
Ongoing charges****:                       1.1%

* includes net revenue of 3.57 pence per share
** based on interim dividend of 2.20p per share for the financial year ending
31 October 2014 and final dividend of 3.50p per share in respect of the year
ended 31 October 2013.
*** excludes 6,454,664 shares held in treasury
**** Calculated as a percentage of average net assets and using expenses,
excluding performance fees and interest costs for the year ended 31 October
2013.

Benchmark

Sector Analysis                   Total assets (%)

Pharmaceuticals & Biotechnology       10.4
Tobacco                               10.2
Oil & Gas                              9.9
Support Services                       9.9
Life Insurance                         8.8
Travel & Leisure                       6.5
Banks                                  6.3
Household Goods & Home Construction    5.0
General Retailers                      4.8
Media                                  4.3
Non Life Insurance                     4.0
Mining                                 3.8
Food Producers                         3.3
Electronic & Electrical Equipment      2.2
Beverages                              2.0
Financial Services                     1.5
Personal Goods                         1.3
Net Current Assets                     5.8
                                     -----
Total                                100.0
                                     -----

Ten Largest Equity Investments

Company                        % of Total assets

Royal Dutch Shell B                   6.9
British American Tobacco              6.3
HSBC                                  6.3
AstraZeneca                           5.3
Reed Elsevier                         4.3
GlaxoSmithKline                       4.2
Wolseley                              4.2
Imperial Tobacco                      3.9
Prudential                            3.8
Rio Tinto                             3.8

Commenting on the markets, Adam Avigdori and Mark Wharrier representing the
Investment Manager noted:

Markets

UK equities fell in the first half of the month as fears over global growth
coupled with the US Federal Reserve ceasing asset purchases weighed on markets
around the world. Investor concerns were apparent in the US Volatility Index,
which showed a sharp increase in volatility to its highest level since December
2011. Towards the end of the month equities rallied with positive economic data
from China, better than expected earnings and GDP in the US and new stimulus
from the European Central Bank.

Portfolio Performance

The Company returned 0.3%* in October, outperforming the FTSE All-Share Index
return of -0.7%. This brings the year to date return to 6.3%, which is ahead of
the FTSE All-Share Index return of 1.0%.

The portfolio benefited from positions in Wolseley, Reed Elsevier and Dixons
Carphone. Wolseley continued to perform well following the announcement of positive 
results at the end of September and reassuring US economic data, whilst Reed Elsevier
re-iterated its outlook, improving returns and cashflow and the near completion
of a £600 million share buy back. Dixons Carphone announced that cost savings
would be achieved earlier than previously forecast. Shire was a positive
contributor to relative performance as the shares fell following the withdrawal
of Abbvie's bid, the portfolio position had been sold earlier in the year after
the bid was announced. The main detractor to relative performance was Essentra,
following a third quarter update that showed weakness in it porous technologies
business.

Activity

Activity during the period included new purchases of Diageo and Marks & Spencer
and additions to Prudential, Carnival and Rio Tinto. We reduced GlaxoSmithKline
and 3i Group and sold Vodafone and Aviva.

Outlook / Strategy

While the outlook for the global economy has improved in recent years, it
remains fragile. Eurozone economic activity remains subdued despite an
increasingly supportive policy response from the European Central Bank, whilst
in the US the ending of quantitative easing is contributing to uncertainty. We
continue to focus more on the specific drivers of individual companies and the
ability to determine their future rather than relying on a specific macro
outcome. Given the outlook for both economic growth and interest rates remains
uncertain, we seek those companies that can drive returns through self-help and
have a clear strategy to deploy the cash flow they generate.

The portfolio is primarily invested in high free cash flow companies that can
sustain cash generation and pay a growing dividend yield. It also has exposure
to companies with sustainable growth franchises and turnaround situations.

* NAV - Inc. performance.

18 November 2014

ENDS

Latest information is available by typing www.blackrock.co.uk/brci on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.